Best Selling 5'-Uridylic Acid Sodium Salt Powder

Potent Umami Enhancement with Synergistic Effects

Intense Umami Profile: Contributes a distinct "brothy, savory" taste, with an umami threshold of ~0.01% (w/v), comparable to inosinic acid (IMP) but with a smoother aftertaste.

Synergy with Glutamates: When combined with monosodium glutamate (MSG), UMP-Na₂ amplifies umami intensity by 3–5 fold, reducing overall sodium content in seasonings.

Broad Flavor Enhancement: Effective in meat analogs, soups, snacks, and plant-based proteins, masking bitterness in low-sodium or fortified foods.

Superior Chemical Stability and Formulation Flexibility

Thermal Resistance: Stable up to 121°C (autoclaving conditions), maintaining activity in processed meats, canned goods, and instant noodles.

pH Adaptability: Remains soluble across pH 3–9, suitable for acidic sauces (e.g., ketchup) and alkaline ramen broths without precipitation.

Hygroscopic Control: Crystalline structure minimizes caking in dry blends, enabling easy dispersion in spice mixes or soup bases.

Low Allergen Profile: Free of gluten, yeast, and animal-derived components, appealing to clean-label and allergen-free formulations.

Nutritional Significance in Infant Nutrition and Functional Foods

Infant Formula Fortification: As a key nucleotide in human breast milk, UMP supports immune development, gut maturation, and cognitive function in infants. Global regulations (e.g., EU Commission Regulation 2016/127) approve its addition to infant foods.

Immune Health Supplements: Oral administration enhances mucosal immunity in elderly populations, with clinical trials showing reduced respiratory infections in UMP-supplemented groups.

Gut Microbiome Modulation: Acts as a prebiotic substrate for beneficial bacteria (e.g., Bifidobacterium), improving intestinal barrier function in functional beverages.

Regulatory Compliance and Safety Leadership

GRAS & Global Approvals: Recognized as safe by FDA (GRAS notice No. 000579), EU (EC No. 1336/2008), and Japan (FOSHU designation), enabling seamless market entry.

Low Toxicity Profile: Acute oral LD₅₀ > 5 g/kg in rats, with no observed adverse effects at typical food additive levels (0.05–0.5% w/w).

Halal & Kosher Certification: Synthetic production routes (fermentation or chemical synthesis) allow certification for religious dietary requirements.

Cost-Effectiveness and Scalable Production

Efficient Manufacturing: Industrial synthesis via microbial fermentation (e.g., E. coli overexpression) or enzymatic hydrolysis of RNA, yielding >98% pure crystals at competitive costs.

Economies of Scale: Annual production capacities exceed 1,000 tons, with pricing 30–50% lower than rare nucleotides like guanosine monophosphate (GMP).

Sustainable Sourcing: RNA feedstocks from food industry byproducts (e.g., yeast extract, fish sperm), aligning with circular economy principles.